NEUTRISCI ANNOUNCES INITIAL ORDER FROM CRYOPHARM

VANCOUVER, British Columbia, June 19, 2019 (GLOBE NEWSWIRE) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the [...]

NEUTRISCI ENTERS INTO LOI WITH FALCON TECHNOLOGIES INC. dba ECOGROWTH STRATEGIES TO MANUFACTURE SUBLINGUAL CBD PRODUCTS

– Signing of definitive agreement expected in early Q2 – First orders expected in early Q3 Vancouver, British Columbia – March 25, 2019 – Neutrisci International Inc. (the [...]

NEUTRISCI ANNOUNCES PRODUCT SALES INCREASE

Vancouver, British Columbia – February 26, 2019 – Neutrisci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

NEUTRISCI ANNOUNCES EXCLUSIVE LICENSING AGREEMENT FOR CBD TABLET MANUFACTURING & DISTRIBUTION WITH LASANTA BOTANICALS LTD.

Vancouver, British Columbia – December 6, 2018 – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) has entered into a memorandum of [...]

NEUTRISCI AND NATURALLY SPLENDID USA ANNOUNCE EXPANDED BINDING TERMS OF PARTNERSHIP AND ADDED DISTRIBUTION OF HEMPOMEGA™ AND CANNABIDIOL (CBD) SUBLINGUAL TABLETS

Vancouver, British Columbia – October 11, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) is pleased to [...]